FDA officials have approved Luminopia's sale of VR glasses for treating children with amblyopia.
Amblyopia is also called lazy eye syndrome. This disease manifests itself in the form of a decrease in visual acuity in one or both eyes. This is due to functional disorders of the brain, due to which it cannot receive normal signals from the eyes. So, the brain is not able to combine the picture from two organs into a single one, which is why it begins to give preference to one of them, as if “turning off” the other. Subsequently, this leads to a deterioration in the vision of the weak eye.
Representatives of the Luminopia company, in turn, came up with a way to avoid the development of this disease using virtual reality glasses. So, they offered to broadcast the picture to each body separately. For example, while watching films and other video content, the patient observes pictures of different contrast – for a strong eye it is reduced to 15% of the contrast of a weak one. Thanks to this, the brain needs to process images from a weak organ, which, in turn, stops the loss of vision and heals the disease.
News stories cannot be equated with a doctor's prescription. Before making a decision, consult a specialist.
Read also:
DNS sells smartphone POCO X3 Pro with 256 GB of memory at the lowest price (UPD: the shop was closed)
Scientists have caught strange radio waves from the center of the Galaxy
Scientists have established the smell that people smell before death
The reason why people do not lose weight even with diet and sports is named
What happens if you install RAM from laptops in a desktop computer through an adapter
